Welcome to the International Cancer Research and Drug Discovery Conference (i-Cancer Congress), a gathering of medical professionals, researchers, and patients dedicated to advancing the fight against cancer. This year's conference will take place on June 21, 2024 at London, UK and will feature talks and presentations from leading experts in the field.
Our goal is to foster a collaborative environment that encourages the exchange of ideas and insights, and ultimately leads to improvements in medical practice.
i-Cancer Congress will cover a wide range of topics in the field of cancer research—clinical trials, basic research, and translational research—in order to better understand cancer and find new paths for shaping and delivering the best, most effective cancer treatments. Attendees will have the opportunity to learn about the latest advances in oncology, and to network with other professionals and patients.
i-Cancer Congress will provide you the opportunity to attend keynote speeches, workshops, and panel discussions led by experts in their respective fields. Our lineup of speakers includes some of the most prominent researchers, doctors, and patient advocates in the field of oncology. They will be sharing their insights and expertise in a series of presentations and panel discussions, providing attendees with a comprehensive overview of the latest developments in cancer research and treatment. . We will have a diverse range of healthcare professionals and researchers from all over the world, making it an excellent opportunity for companies to connect with potential clients and build lasting relationships.
Whether you are a physician, nurse, researcher, or healthcare administrator, you will find valuable insights and networking opportunities at our conference.
Register now to secure your spot and take advantage of early bird pricing. We look forward to seeing you at the conference!
The global oncology market was valued at US$ 286.04 billion in 2021 and is anticipated to reach US$ 581.25 billion by 2030, increasing at an amazing 8.2% CAGR between 2022 and 2030. Cancer is a significant public health issue, affecting millions of people globally. Despite significant advancements in cancer treatment, the incidence of the disease continues to rise. Cancer is a significant public health issue that continues to drive significant investment and innovation in the global and UK markets. The increasing prevalence of the disease, coupled with the development of new treatment options and government funding, is expected to drive growth in the industry in the coming years. As the market evolves, it will be important for stakeholders to stay abreast of key trends and drivers in the industry to effectively capitalize on new opportunities. The major drivers of the global cancer market include the development of targeted therapies, growing demand for personalized medicine, and increasing government funding for cancer research.
Participate in i-Cancer Congress to experience the booming industry and expose your career and company to new opportunities from around the world.
University of Washington USA
For i-WH2022
University of Salford UK
For i-WH2022
King Faisal Specialist H&RC Saudi Arabia
For i-WH2022
UWE Bristol UK
For i-WH2022
Chung Shan Medical University Taiwan
For i-WH2022
University of Modena and Reggio Emilia Italy
For i-WH2022
SESCS Spain
For i-WH2022
SESCS Spain
For i-WH2022
University of Sheffield UK
For i-WH2019
The Institute of Cancer Research UK
For i-WH2019
eclaireMD Foundation USA
For i-WH2019
French National Institute of Health (INSERM) France
For i-WH2019
National Defense Medical Center Taiwan
For i-WH2019
The London College UK
For i-WH2019
INSERM France
For i-WH2019
Yeovil District Hospital UK
For i-WH2019
AlFarabi College of Medicine Riyadh
For i-WH2019
University of Florida Health USA
.jpg)
Imperial College London UK
Tulane University USA
Thank you for the conference note. The conference covered a diverse group of topics with a true international flavor in terms of the attending delegates.
(For i-Pharma Congress 2018)
It offered everything we needed. It gives all participants a productive conference experience. We’ll come back year after year
(For i-Pharma Congress 2018)
The conference was good, even some speakers could not attend because of the weather. It was a great experience for me and I am really glad for the experience.
(For i-Pharma Congress 2018)
I would like to thank you for the opportunity to make the presentation last Thursday in Philadelphia. It was a good experience and I would like to think that my presentation was well received by the audience.
(For i-Pharma Congress 2018)
My US experience was very good and will always fondly cherish the memories. Would like to be back again in a year or so. I wish we could meet.
(For i-Pharma Congress 2018)
It has been a great opportunity to share the experience and state-of-the-art in the pharmaceutical field among academia and industry. It served a good platform for efficient networking. I would like to acknowledge the organizing committee for the invitation to contribute to the conference with a talk upon YRF.
(For i-Pharma Congress 2018)
Thank you for organising the conference, it was done very well indeed.
(For i-WomenHealth 2019)
Thank you for sending the photographs. Also a special mention in thanking you for all the efforts and arrangements made by you for this conference.
(For i-WomenHealth 2019)
I would like to thank you and the organizing committee for inviting me to deliver a talk. It received good attention and applause. Was an excellent experience for me. Have to say though that the strength of the audience was slim. The meeting was well organized and the venue was good.
(For i-WomenHealth 2019)
I enjoyed coming and I am still continuing my scientific activities here in London.
(For i-WomenHealth 2019)
Many thanks to you for your nice message with the photos of the conference. They were nice and a lot. Hope to see you in the next conference.
(For i-WomenHealth 2019)
I enjoyed the conference and was glad about the positive feedback that I received after my talk. It was unfortunate that many speakers left immediately after their talk rather than staying for the entire conference. Thanks again for your hard work and organization.
(For i-Pharma Congress 2019)
I thought it was a great conference. Thanks again for all the hard work that went into it.
(For i-Pharma Congress 2019)
.png)
-iWomenHealth2022.jpg)
.webp)